Acute Pulmonary Embolism (PE) is the most serious clinical presentation of venous thromboembolism (VTE), a leading cause of cardiovascular mortality, exceeded only by stroke and myocardial infarction. Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe chronic form of CTED and it occurs in 2-4% of patients after acute PE. In Portugal little is known about PE epidemiology and its outcomes, including complications like CTED. The main goal of this study is, therefore, to understand PE epidemiology and complications in the northern region of Portugal. This information can enable the organization of a structured health care network that can potentially benefit all PE patients.
Study Type
OBSERVATIONAL
Enrollment
500
Determine Pulmonary Embolism (PE) prevalence in Portugal
Number cases per year
Time frame: From date of inclusion until the end of the study currently planned (3 to 5 years)
Identification of Pulmonary Embolism (PE) risk factors and comorbidities
Frequency of risk factors and comorbidities
Time frame: From date of inclusion until the end of the study currently planned (3 to 5 years)
Determine Pulmonary Embolism (PE) clinical management.
Identification of diagnostic of diagnostic and treatment profile
Time frame: From date of inclusion until the end of the study currently planned (3 to 5 years)
Access incidence rate of Chronic Thromboembolic Disease (CTED) with or without pulmonary hypertension after acute PE.
ratio between the number of patients with CTED with or without pulmonary hypertension and total number of patients with PE
Time frame: From 6 months after date of inclusion until the end of the study currently planned (2 to 5 years)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.